| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.61T | 2.51T | 2.41T | 2.48T | 2.10T | 1.60T |
| Gross Profit | 356.75B | 317.76B | 299.98B | 314.84B | 252.35B | 170.59B |
| EBITDA | 108.66B | 121.02B | 126.53B | 154.70B | 125.28B | 58.89B |
| Net Income | 114.94B | 110.64B | 100.77B | 111.25B | 82.33B | 27.00B |
Balance Sheet | ||||||
| Total Assets | 3.43T | 3.17T | 2.97T | 2.72T | 2.71T | 2.35T |
| Cash, Cash Equivalents and Short-Term Investments | 219.16B | 199.18B | 209.41B | 254.28B | 282.43B | 297.66B |
| Total Debt | 1.27T | 1.19T | 1.01T | 955.11B | 1.13T | 985.57B |
| Total Liabilities | 2.33T | 2.16T | 2.02T | 1.84T | 1.95T | 1.70T |
| Stockholders Equity | 1.06T | 968.96B | 924.08B | 837.71B | 728.01B | 619.11B |
Cash Flow | ||||||
| Free Cash Flow | 5.57B | -60.05B | 85.09B | 145.96B | 46.71B | 61.08B |
| Operating Cash Flow | 46.08B | -16.69B | 112.19B | 171.64B | 65.08B | 84.97B |
| Investing Cash Flow | -100.81B | -90.81B | -8.60B | 30.72B | -140.28B | -37.66B |
| Financing Cash Flow | 64.83B | 103.09B | -165.49B | -231.93B | 48.35B | -38.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥9.48T | 14.11 | 13.39% | 2.29% | 9.62% | 25.71% | |
71 Outperform | ¥16.04T | 16.87 | 15.23% | 2.11% | 0.93% | 15.80% | |
69 Neutral | ¥7.12T | 15.10 | 12.86% | 2.48% | 3.19% | 72.26% | |
68 Neutral | ¥21.43T | 13.18 | 7.39% | 2.94% | -7.54% | -35.70% | |
67 Neutral | ¥18.23T | 17.68 | 11.47% | 2.28% | -1.33% | -7.40% | |
65 Neutral | ¥1.21T | 7.20 | 11.17% | 3.24% | 2.12% | 18.93% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |